Clinical Gastroenterology and Hepatology
Volume 10, Issue 5 , Pages 494-500, May 2012

Factors Associated With Persistent and Nonpersistent Chronic Constipation, Over 20 Years

  • Rok Seon Choung

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
  • ,
  • G. Richard Locke III

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationReprint requests Address requests for reprints to: G. Richard Locke III, MD, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. fax: (507) 538-5820
  • ,
  • Enrique Rey

      Affiliations

    • Division of Gastroenterology and Hepatology, Hospital Clinico San Carlos, Complutense University, Madrid, Spain
  • ,
  • Cathy D. Schleck

      Affiliations

    • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
  • ,
  • Charles Baum

      Affiliations

    • Takeda Pharmaceuticals North America, Inc, Chicago, Illinois
  • ,
  • Alan R. Zinsmeister

      Affiliations

    • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
  • ,
  • Nicholas J. Talley

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia

published online 30 January 2012.

Background & Aims

The prevalence of chronic constipation (CC) has been reported to be as high as 20% in the general population, but little is known about its natural history. We estimated the natural history of CC and characterized features of persistent CC and nonpersistent CC, compared with individuals without constipation.

Methods

In a prospective cohort study, we analyzed data collected from multiple, validated surveys (minimum of 2) of 2853 randomly selected subjects, over a 20-year period (median, 11.6 years). Based on responses, subjects were characterized as having persistent CC, nonpersistent CC, or no constipation. We assessed the association between constipation status and potential risk factors using logistic regression models, adjusting for age and sex.

Results

Of the respondents, 84 had persistent CC (3%), 605 had nonpersistent CC (21%), and 2164 had no symptoms of constipation (76%). High scores from the somatic symptom checklist (odds ratio [OR] = 2.1; 95% confidence interval [CI], 1.3–3.4) and frequent doctor visits (OR = 2.0; 95% CI, 1.0–3.8) were significantly associated with persistent CC, compared with subjects with no constipation symptoms. The only factor that differed was increased use of laxatives or fiber among subjects with persistent CC (OR = 3.0; 95% CI, 1.9–4.9).

Conclusions

The prevalence of constipation might be exaggerated—the proportion of the population with persistent CC is low (3%). Patients with persistent and nonpersistent CC have similar clinical characteristics, although individuals with persistent CC use more laxatives or fiber. CC therefore appears and disappears among certain patients, but we do not have enough information to identify these individuals in advance.

Keywords:  SSC , Epidemiology , Determinants , Diagnosis

Abbreviations used in this paper:  BDQ, Bowel Disease Questionnaire, BM, bowel movement, BMI, body mass index, CC, chronic constipation, CI, confidence interval, GI, gastrointestinal, IBS, irritable bowel syndrome, OR, odds ratio, SSC, Somatic Symptom Checklist

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Watch this article's video abstract and others at http://tiny.cc/bz9jv.

 Conflicts of interest This author discloses the following: Dr Talley and Mayo Clinic have licensed the Talley Bowel Disease Questionnaire. The remaining authors disclose no conflicts.

 Funding This study was sponsored by Takeda Pharmaceuticals and was made possible by the Rochester Epidemiology Project (Grant R01-AG034676 from the National Institute on Aging).

PII: S1542-3565(12)00115-2

doi:10.1016/j.cgh.2011.12.041

Clinical Gastroenterology and Hepatology
Volume 10, Issue 5 , Pages 494-500, May 2012